All News

Approval for the technology, which integrates with a smartphone, came sooner than company officials expected.

A novel microRNA gene signature could guide earlier intervention in pancreatic cancer.

An expert panel of ASCO developed recommendations for advanced lung cancer treatment after reviewing published literature.

The new guidance released by HRSA proposes to improve oversight over the drug pricing program.

Quality may be getting better, but the GAO was not pleased that the VA did not have a handle on the drop-off in evaluations.

A large majority of healthcare organizations have been compromised by a cyberattack during the last 2 years and only half believe they are adequately prepared for preventing these attacks.

The latest option combines empagliflozin and metformin hydrochloride.

Research from The Commonwealth Fund found little indication that risk segmentation is causing adverse effects in the insurance market either in coverage sold on the exchanges and coverage sold off the exchanges.

Pharmacy cost trends are expected to increase 10% up from 6.3% the year before, with specialty pharmacy trends experiencing the largest increases, according to a survey from Aon Health.

Top managed care news this week included results for accountable care organizations during 2014, avoiding delays in cancer diagnosis with the use of an electronic health record trigger, and 3 studies look at colorectal cancer screening.

Although the fee-for-service model of reimbursement has been blamed as an reason for high healthcare costs in America, a report from HealthPocket found that eliminating this payment model in provider-owned health plans did not produce the cheapest health plans.

In Texas, a new law will allow more patients to get help negotiating lower bills from hospital-based doctors who are out of network instead of being stuck with huge bills even when the hospital is in their health insurer's provider network.

When measuring quality of pediatric care, hospitals should include different-hospital readmission along with same-hospital readmission, the authors conclude.

Both ExpressScripts and CVS Health say the new class of cholesterol-fighting drugs will be generally unavailable until their P&T committees complete evaluations, and negotiations for discounts or exclusive deals occur.

The study published in JNCI has identified CES2 expression as a predictor of response to FOLFIRINOX.

In the second quarter of 2015 the healthcare spending growth rate was 5.9%, a decline from 6.6% in the first quarter of the year, but the health spending growth rate is still 2 percentage points higher than rates experienced between 2009 and 2013.

With 1 biosimilar already approved in the US, the FDA has finally released draft guidelines for naming these new products.

The study sheds light on a potential way to reconfigure the school day to create opportunities for physical activity. More work would be needed, researchers say.

The approval of evolocumab (Repatha) creates competition in the new class of PCSK9 cholesterol-fighting therapies and managed care plans and pharmacy benefit managers are expected to take full advantage to hold down costs.

Published in the journal Neurology, the study identified childhood cancer, along with hypertension and age, as a risk factor for recurrent stroke.

A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.

Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state's insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.

The use of hospital observation instead of hospital admission is becoming increasingly common for Medicare beneficiaries; however, it may mean unexpectedly higher out-of-pocket costs.

Both surveys and peer-reviewed research show patients like telehealth services. CVS' announcement comes after a successful pilot program showed a collaboration of telehealth and the retail clinics produced good results for patients.

A stepped care algorithm developed by scientists has the potential to manage blood pressure in patients who develop intolerance to guideline-based regimens.

The Biosimilars Council wants CMS to hold back on Medicare Part B reimbursement for biosimilars.

The study is more evidence that obesity is not just linked to type 2 diabetes but may cause it to occur.

An analysis of provider networks offered in the Affordable Care Act's marketplaces found large variation of the prevalence narrow networks among the states, according to researchers at the University of Pennsylvania.

An article published in the Journal of Clinical Oncology finds that survivorship care plans may not greatly improve patient satisfaction with their care.

The results for 2014, which was Year 3 of the program, revealed winners and losers and showed that ACOs may not be the only solution to hold down the cost of healthcare.